Exagen Future Growth

Future criteria checks 1/6

Exagen is forecast to grow earnings and revenue by 16.6% and 13% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be -252.9% in 3 years.

Key information

16.6%

Earnings growth rate

18.1%

EPS growth rate

Biotechs earnings growth35.3%
Revenue growth rate13.0%
Future return on equity-252.9%
Analyst coverage

Good

Last updated19 Mar 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:E08A - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202675-15-8-84
12/31/202563-19-13-146
12/31/202454-24-18-186
12/31/202353-24-15-14N/A
9/30/202352-32-30-29N/A
6/30/202353-35-34-32N/A
3/31/202346-45-37-33N/A
12/31/202246-47-36-32N/A
9/30/202245-40-37-32N/A
6/30/202243-39-36-31N/A
3/31/202248-31-28-25N/A
12/31/202148-27-23-20N/A
9/30/202148-23-19-18N/A
6/30/202147-20-16-15N/A
3/31/202143-17-16-15N/A
12/31/202042-17-15-14N/A
9/30/202040-17-15-14N/A
6/30/202039-29-14-14N/A
3/31/202041-31-11-11N/A
12/31/201940-30-10-10N/A
9/30/201940-31-8-8N/A
6/30/201938-18-9-8N/A
3/31/201935-18-8-8N/A
12/31/201832-18-9-9N/A
12/31/201727-33-12-11N/A
12/31/201518-21N/A-12N/A
9/30/201518-21N/A-11N/A
6/30/201517-23N/A-10N/A
3/31/201515-17N/A-10N/A
12/31/201412-17N/A-11N/A
9/30/20149-23N/A-11N/A
6/30/20146-21N/A-10N/A
3/31/20144-19N/A-8N/A
12/31/20133-18N/A-7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: E08A is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: E08A is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: E08A is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: E08A's revenue (13% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: E08A's revenue (13% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: E08A is forecast to be unprofitable in 3 years.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.